STX-241 FIH (F60087CI101)

RMC-LUNG-101A

RMC-LUNG-101

LB100

RMC-6291-101

STX-721-101

StrateGIST 1 (IDRX-42-001)

D6900C00001

CA1201001

M22TGA

CTLR-101

IMC-F106C-101 (PRAME)

TCD17620

MCLA-129-CL01

D9570C00001

GO43860

XL092-001

SGNPDL1V-001

INCB 123667-101

PROACTIVE

1479-0001

CyPep-1

VHIO17002

MCLA-128-CL01

KEYNOTE 158

DESTINY-Lung03

1-hele-groep

image

rich-content


<p style="text-align:center; margin-bottom:8.5rem;" class="has-text-align-center">Many different disciplines work together at the Early Drug Development Center (EDDC). The EDDC accommodates 6 investigators and approximately 40 FTE scientific support personnel. Everyone on this team shares the same mission: contribute to the development of promising cancer treatments. You can see an overview of our team on this page.</p>



<h2 class="wp-block-heading has-text-align-center">Overview of our specialists</h2>


acf/team-member-tiles

Marjolein van Mil

Nurse Practitioner

Neeltje Steeghs

Medical Oncologist and Clinical Pharmacologist | Head of Early Drug Development Center & Head of Clinical Research Unit

Marloes van Dongen

Medical Oncologist and Clinical Pharmacologist 

Coby Guit

Coby Guijt

Gerrina Ruiter

Pulmonologist specialized in Thoracic Oncology

Frans Opdam

Medical Oncologist and Clinical Pharmacologist

Sofie Boutkan

Clinical Alliance Manager

Anna Willemsma

Organisational Support

Lois-gradient

Nurse Practitioner in Training

Lois Stam

Empty Page

Our team - NKI